Icagen: Clinical Trials

5 trials sponsored by Icagen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 32Terminated 2

Follow Icagen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
senicapoc, Placebo - Exercise Induced Asthma
Phase 2CompletedIcagen692009-03-012011-07-14
Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects
senicapoc, Placebo - Atopic Asthma
Phase 2CompletedIcagen342008-10-012011-07-14
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
ICA-17043 - Sickle Cell Disease, Sickle Cell Anemia
Phase 3TerminatedIcagen512006-02-012007-09-11
A Stratified Sickle Event Randomized Trial (ASSERT)
ICA-17043 - Sickle Cell Disease
Phase 3TerminatedIcagen2972005-02-012008-03-27
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Low Dose ICA-17043, High dose ICA-17043, Placebo - Sickle Cell Disease, Sickle Cell Anemia
Phase 2CompletedIcagen902002-02-012011-07-18

Conditions studied

Anemia, Sickle Cell (3)  ·  Inflammation (2)  ·  Anemia (1)  ·  Asthma (1)  ·  Asthma, Exercise-Induced (1)  ·  Bronchial Spasm (1)

Interventions

senicapoc (5)

Countries

United States (4)  ·  United Kingdom (2)  ·  Brazil (1)  ·  France (1)  ·  Jamaica (1)  ·  Trinidad and Tobago (1)

Top investigators

Jonathan W Stocker, Ph.D. (1)  ·  Jonathan W Stocker, PhD (1)  ·  Jonathon Stocker, Ph.D. (1)  ·  Kenneth I Ataga, MD (1)  ·  Tak H Lee, FRCP (1)

Results publications

PMID 18192510